- LRMR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-1 Filing
Larimar Therapeutics (LRMR) S-1IPO registration
Filed: 12 Jan 15, 12:00am
Exhibit 16.1
January 8, 2015
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by Zafgen, Inc. under the heading “Change in Accounting Firm Relationships”, in this registration statement on Form S-1 and we agree with the statements concerning our Firm under that heading.
Very truly yours,
/s/ Edelstein and Company LLP
Edelstein and Company LLP
1
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.